Description

• Title:
  Effects of dupilumab on hair in patients with atopic dermatitis - a review of the literature
• Creator:
  Marczak, Aleksandra;
  Hordejuk, Michalina;
  Hyjek, Michał;
  Szymkiewicz, Karolina
• Description:
  Dupilumab is a recombinant human monoclonal antibody of the IgG4 class. Its mechanism of action can most broadly be described as inhibition of interleukin 4 and 13-mediated signal transduction. These cytokines are the main drivers of inflammatory diseases such as atopic dermatitis (AD) and asthma. Currently, dupilumab is the subject of many studies and scientific articles. More and more papers are being written about the efficacy of this drug and the side effects. Based on publications from the PubMed database, we present selected cases of atopic dermatitis patients who experienced uncharacteristic and unclear hair-related changes, such as hair loss, growth and change in hair colour, after dupilumab administration.
• Object availability:
  free access
• Rights: https://creativecommons.org/licenses/by-nc-sa/4.0 ;
  Prawa autorskie (c) 2022 Aleksandra Marczak, Michalina Hordejuk, Michał Hyjek, Karolina Szymkiewicz
• Date:
  2022.11.08
• Type:
  info:eu-repo/semantics/article;
  info:eu-repo/semantics/publishedVersion
• Language:
  English
• Source:
  Journal of Education, Health and Sport; Vol. 12 No. 11 (2022); 328-333;
  Journal of Education, Health and Sport; Tom 12 Nr 11 (2022); 328-333;
  2391-8306
• Format:
  application/pdf
• Publisher:
  Nicolaus Copernicus University, Toruń, Poland
• Relation: https://apcz.umk.pl/JEHS/article/view/39918/33625
• Subject:
  dupilumab;
  atopic dermatitis;
  alopecia areata;
  side effect;
  monoclonal antibody;
  mollusum contagiosum;
  alopecia totalis
• Identifier: https://apcz.umk.pl/JEHS/article/view/39918
• Data provider:
  Akademicka Platforma Czasopism
• Can I use it?:
  seek permission
• Type:
  text